J Am Chem Soc1999,121(50):11912–11913.CrossRef selleck inhibitor 21. Wright SAI, Zumoff CH, Schneider L, Beer SV:Pantoea agglomerans strain EH318 produces two antibiotics that inhibit Erwinia amylovora in vitro. Applied and environmental microbiology2001,67(1):284–292.CrossRefPubMed 22. Giddens SR, Feng Y, Mahanty HK:Characterization of a novel phenazine antibiotic gene cluster in Erwinia herbicola Eh1087. Mol Microbiol2002,45(3):769–783.CrossRefPubMed 23. Van Rostenberghe H, Noraida

R, Wan Pauzi WI, Habsah H, Zeehaida M, Rosliza AR, Fatimah I, Nik Sharimah NY, Maimunah H:The clinical picture of neonatal infection with Pantoea species. Jpn J Infect Dis2006,59:120–121.PubMed 24. Cruz AT, Cazacu AC, Allen CH:Pantoea agglomerans , a plant pathogen causing human disease. J Clin Microbiol2007,45(6):1989–1992.CrossRefPubMed 25. Kratz A, Greenberg D, Barki Y, Cohen E, Lifshitz M:Pantoea agglomerans as a cause of septic arthritis after palm tree thorn injury; case report and literature review. Arch Dis Child2003,88:542–544.CrossRefPubMed 26. Geere JW:Enterobacter agglomerans : the clinically important plant pathogen. Palbociclib mw Can Med Assoc J1977,116:517–519.PubMed 27. Bergman KA, Arends JP, Schölvinck

EH:Pantoea agglomerans septicemia in three newborn infants. Pediatr Infect Dis J2007, (26):453–454. 28. Ruimy R, Genauzeau E, Barnabe C, Beaulieu A, Tibayrenc M, Andremont A:Genetic diversity of Pseudomonas aeruginosa strains isolated from LY294002 ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental

water. Infect Immun2001,69:584–588.CrossRefPubMed 29. Lanotte P, Watt S, Mereghetti L, Dartiguelongue N, Rastegar-Lari A, Goudeau A, Quentin R:Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J Med Microbiol2004,53:73–81.CrossRefPubMed 30. Khan NH, Ishii Y, Kimata-Kino N, Esaki H, Nishino T, Nishimura M, Kogure K:Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates. Microbial Ecology2007,53:173–186.CrossRefPubMed 31. Kurz CL, Chauvet S, Andrès E, Aurouze M, Vallet I, Michel GP, Uh M, Celli J, Filloux A, De Bentzmann S,et al.:Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J2003,22:1451–1460.CrossRefPubMed 32. Coenye T, Vandamme P:Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol2003,5:719–729.CrossRefPubMed 33. Tabacchioni S, Ferri L, Manno G, Mentasti M, Cocchi P, Campana S, Ravenni N, Taccetti G, Dalmastri C, Chiarini L,et al.:Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complex. FEMS Microbiol Lett2008,281:175–182.CrossRefPubMed 34.